These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 17512780

  • 1. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M, Ferri R, Zucconi M, Oldani A, Fantini ML, Castronovo V, Ferini-Strambi L.
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [Abstract] [Full Text] [Related]

  • 2. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [Abstract] [Full Text] [Related]

  • 3. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G, Dolso P, Canesin R, Cancelli I, Valente M, Gigli GL.
    Neuropsychobiology; 2006 Jun; 54(3):195-200. PubMed ID: 17314491
    [Abstract] [Full Text] [Related]

  • 4. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B.
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [Abstract] [Full Text] [Related]

  • 7. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M, Ferri R, Zucconi M, Clemens S, Giarolli L, Bottasini V, Ferini-Strambi L.
    Neurology; 2011 Jul 12; 77(2):110-7. PubMed ID: 21715702
    [Abstract] [Full Text] [Related]

  • 8. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.
    Sleep Med; 2008 Dec 12; 9(8):874-81. PubMed ID: 18952497
    [Abstract] [Full Text] [Related]

  • 9. Dissociation of periodic leg movements from arousals in restless legs syndrome.
    Manconi M, Ferri R, Zucconi M, Bassetti CL, Fulda S, Aricò D, Ferini-Strambi L.
    Ann Neurol; 2012 Jun 12; 71(6):834-44. PubMed ID: 22718547
    [Abstract] [Full Text] [Related]

  • 10. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).
    Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2008 Jul 12; 9(5):537-41. PubMed ID: 18276187
    [Abstract] [Full Text] [Related]

  • 11. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.
    Ferri R, Manconi M, Plazzi G, Bruni O, Cosentino FI, Ferini-Strambi L, Zucconi M.
    Sleep Med; 2012 May 12; 13(5):529-35. PubMed ID: 22341907
    [Abstract] [Full Text] [Related]

  • 12. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Stiasny-Kolster K, Oertel WH.
    Neuropsychobiology; 2004 May 12; 50(1):65-70. PubMed ID: 15179023
    [Abstract] [Full Text] [Related]

  • 13. Night-to-night variability in periodic leg movements in patients with restless legs syndrome.
    Sforza E, Haba-Rubio J.
    Sleep Med; 2005 May 12; 6(3):259-67. PubMed ID: 15854857
    [Abstract] [Full Text] [Related]

  • 14. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL.
    Sleep Med; 2005 Mar 12; 6(2):141-7. PubMed ID: 15716217
    [Abstract] [Full Text] [Related]

  • 15. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M, Hundemer HP, Quail D, Riemann D, Voderholzer U, Trenkwalder C.
    Clin Neurophysiol; 2007 Jul 12; 118(7):1532-7. PubMed ID: 17531532
    [Abstract] [Full Text] [Related]

  • 16. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.
    J Neurol Sci; 2010 Jul 15; 294(1-2):62-6. PubMed ID: 20451927
    [Abstract] [Full Text] [Related]

  • 17. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
    Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J.
    Mov Disord; 2006 Sep 15; 21(9):1404-10. PubMed ID: 16755554
    [Abstract] [Full Text] [Related]

  • 18. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.
    Shinno H, Oka Y, Otsuki M, Tsuchiya S, Mizuno S, Kawada S, Innami T, Sasaki A, Hineno T, Sakamoto T, Inami Y, Nakamura Y, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):522-6. PubMed ID: 20156514
    [Abstract] [Full Text] [Related]

  • 19. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S, Wetter TC.
    Brain; 2008 Apr 16; 131(Pt 4):902-17. PubMed ID: 17932100
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
    Garcia-Borreguero D, Winkelman J, Adams A, Ellis A, Morris M, Lamb J, Layton G, Versavel M, Sumanirole in RLS Study Group.
    Sleep Med; 2007 Mar 16; 8(2):119-27. PubMed ID: 17239657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.